Reproductive & hormonal

Oxytocin

The labour hormone, used in every obstetric unit in the world. Its 'bonding' reputation rest on much weaker human evidence than its obstetric record.

Strong evidenceApproved drugAdd to compare
01

What it is

Oxytocin is a nine-amino-acid peptide made in the hypothalamus and released from the posterior pituitary. Synthetic oxytocin (Pitocin, Syntocinon) is an approved medicine used to induce or speed up labour and to control bleeding after birth. Nasal sprays sold online for mood, trust or bonding are a separate, largely unregulated market.

02

How it works

  1. 1

    Binds oxytocin receptors on uterine smooth muscle, causing coordinated contractions that increase in strength and frequency with dose.

  2. 2

    Acts on myoepithelial cells around breast ducts to trigger milk ejection during feeding.

  3. 3

    In the brain, oxytocin acts on reward and social-salience circuits — the basis for 'bonding' claims, which are far better established in animals than in people.

  4. 4

    It also has mild antidiuretic activity, which is why high doses with large fluid volumes can dilute sodium in the blood.

03

What it's studied for

Induction and augmentation of labour (approved)
Prevention and treatment of postpartum haemorrhage (approved)
Support of milk ejection (approved, intranasal in some countries)
Autism and social behaviour (many small trials, mixed results)
Anxiety, trust and pain perception in laboratory studies
04

Reported and studied effects

  • Reliable, dose-dependent uterine contractions
  • Reduced bleeding after birth when used as part of active management of the third stage
  • Small, inconsistent effects on social behaviour in autism trials, with the largest studies showing no clear benefit
  • Intranasal studies in healthy volunteers show modest shifts in trust and attention to social cues

Research protocol notes

Research context only

Research context only — oxytocin is a hospital medicine given under continuous fetal and maternal monitoring, titrated in milli-units per minute. Intranasal doses of 24–40 IU were used in social-cognition research. It must never be self-administered for labour.

These figures are described so you can understand what researchers did. They are not a dose, a schedule, or a suggestion — and they are not a substitute for a doctor.

05

Possible side effects and contraindications

Safety profile

Possible side effects

  • Uterine hyperstimulation, which can distress the fetus
  • Fetal heart-rate changes
  • Water intoxication and low blood sodium at high doses with large fluid volumes
  • Nausea and vomiting
  • Headache
  • Rare anaphylaxis
  • Severe postpartum haemorrhage if bleeding is not managed correctly

Contraindications and cautions

  • Cephalopelvic disproportion or unfavourable fetal position
  • Fetal distress before labour begins
  • Previous major uterine surgery, including classical caesarean
  • Umbilical cord prolapse
  • Known hypersensitivity to synthetic oxytocin

A side-effect list is never complete, and these are not the only situations that warrant caution. Anything unexpected, or anything you are unsure about, should be discussed with a doctor before use.

06

Evidence assessment

Strong evidenceReplicated, large human trials
Replicated, large human trials

Decades of randomised trials and worldwide obstetric use establish the uterine and haemorrhage effects; the behavioural claims rest on small and inconsistent trials and should be rated much lower.

07

References

  1. 01World Health Organization — Recommendations for the prevention and treatment of postpartum haemorrhage
  2. 02European Medicines Agency — Syntocinon product information
  3. 03Intranasal oxytocin and social behaviour trials — PubMed literature search

References link to published literature, regulator pages or literature indexes. Where a link points to a search, it collects the peer-reviewed work on that molecule rather than a single study.